Search Results for: RHOA

Novel Interactant Symbol Name
Associated Pathways
Binding Drugs
Associated Diseases
MCF2L MCF.2 cell line derived transforming sequence like
  • NRAGE signals death through JNK
  • Rho GTPase cycle
  • G alpha (12/13) signalling events
MPRIP myosin phosphatase Rho interacting protein
  • Signaling by BRAF and RAF fusions
MYO9A myosin IXA
  • Rho GTPase cycle
NET1 neuroepithelial cell transforming 1
  • NRAGE signals death through JNK
  • Rho GTPase cycle
  • G alpha (12/13) signalling events
NGEF neuronal guanine nucleotide exchange factor
  • NRAGE signals death through JNK
  • Rho GTPase cycle
  • EPHA-mediated growth cone collapse
  • EPHA-mediated growth cone collapse
  • G alpha (12/13) signalling events
NOTCH1 notch receptor 1
  • Pre-NOTCH Processing in the Endoplasmic Reticulum
  • Pre-NOTCH Transcription and Translation
  • Pre-NOTCH Transcription and Translation
  • Pre-NOTCH Processing in Golgi
  • Pre-NOTCH Processing in Golgi
  • Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells
  • NOTCH1 Intracellular Domain Regulates Transcription
  • NOTCH1 Intracellular Domain Regulates Transcription
  • Activated NOTCH1 Transmits Signal to the Nucleus
  • Activated NOTCH1 Transmits Signal to the Nucleus
  • Constitutive Signaling by NOTCH1 PEST Domain Mutants
  • Loss of Function of FBXW7 in Cancer and NOTCH1 Signaling
  • Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant
  • Constitutive Signaling by NOTCH1 HD Domain Mutants
  • Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants
  • Notch-HLH transcription pathway
  • Defective LFNG causes SCDO3
  • RUNX3 regulates NOTCH signaling
  • RUNX3 regulates NOTCH signaling
  • NOTCH3 Intracellular Domain Regulates Transcription
  • NOTCH3 Intracellular Domain Regulates Transcription
  • NOTCH4 Intracellular Domain Regulates Transcription
  • Bicuspid aortic valve
  • Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia)
OPHN1 oligophrenin 1
  • Rho GTPase cycle
  • Syndromic X-linked mental retardation with epilepsy or seizures, including: West syndrome (WS); Partington syndrome (PRTS); Proud syndrome (ACCAG); XMR and epilepsy (XMRE); MRXHF1; XMR OPHN1-related (MRXSO) ; XELBD; XMR, Christianson type (MRXSC); Creatine deficiency syndrome (XL-CDS); Renpenning syndrome (RENS1); Epilepsy and mental retardation limited to females (EFMR); Periventricular nodular heterotopia (PVNH); Hydrocephalus (XLH); XMR, JARID1C related (MRXSJ); Boerjeson-Forssman syndrome (BFLS); CK syndrome (CKS)
OTUB1 OTU deubiquitinase, ubiquitin aldehyde binding 1
  • Ub-specific processing proteases
  • Ovarian tumor domain proteases
PDE6D phosphodiesterase 6D
  • ARL13B-mediated ciliary trafficking of INPP5E
  • RAS processing
PITPNM1 phosphatidylinositol transfer protein membrane associated 1
  • Synthesis of PI
PKN1 protein kinase N1
  • RHO GTPases activate PKNs
  • Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3
  • Fostamatinib
PKN2 protein kinase N2
  • RHO GTPases activate PKNs
  • Fostamatinib
PLCG1 phospholipase C gamma 1
  • ISG15 antiviral mechanism
  • Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants
  • PLCG1 events in ERBB2 signaling
  • DAG and IP3 signaling
  • PLC-gamma1 signalling
  • Synthesis of IP3 and IP4 in the cytosol
  • Downstream signal transduction
  • Generation of second messenger molecules
  • Role of phospholipids in phagocytosis
  • Role of phospholipids in phagocytosis
  • PECAM1 interactions
  • EGFR interacts with phospholipase C-gamma
  • DAP12 signaling
  • FCERI mediated MAPK activation
  • FCERI mediated Ca+2 mobilization
  • FCERI mediated Ca+2 mobilization
  • Role of second messengers in netrin-1 signaling
  • VEGFR2 mediated cell proliferation
  • VEGFR2 mediated cell proliferation
  • Constitutive Signaling by EGFRvIII
  • Phospholipase C-mediated cascade: FGFR1
  • Phospholipase C-mediated cascade; FGFR2
  • Phospholipase C-mediated cascade; FGFR3
  • Phospholipase C-mediated cascade; FGFR4
  • Signaling by FGFR2 in disease
  • Signaling by FGFR4 in disease
  • Signaling by FGFR1 in disease
  • Signaling by FGFR3 point mutants in cancer
  • RET signaling
  • Activated NTRK2 signals through PLCG1
  • Activated NTRK2 signals through PLCG1
  • Erythropoietin activates Phospholipase C gamma (PLCG)
  • Activated NTRK3 signals through PLCG1
  • Activated NTRK3 signals through PLCG1
  • FCGR3A-mediated IL10 synthesis
  • Signaling by ERBB2 KD Mutants
  • Signaling by ERBB2 ECD mutants
  • Signaling by ERBB2 TMD/JMD mutants
PLD1 phospholipase D1
  • Synthesis of PG
  • Synthesis of PA
  • Role of phospholipids in phagocytosis
  • Neutrophil degranulation
  • Choline
  • LAX-101
  • Choline salicylate
PLEKHG2 pleckstrin homology and RhoGEF domain containing G2
  • NRAGE signals death through JNK
  • Rho GTPase cycle
  • G alpha (12/13) signalling events
PLEKHG4 pleckstrin homology and RhoGEF domain containing G4
PLEKHG6 pleckstrin homology and RhoGEF domain containing G6
PPP1R12A protein phosphatase 1 regulatory subunit 12A
  • Regulation of PLK1 Activity at G2/M Transition
  • RHO GTPases activate PKNs
  • RHO GTPases activate PKNs
  • RHO GTPases activate CIT
  • RHO GTPases Activate ROCKs
  • RHO GTPases activate PAKs
  • RHO GTPases activate PAKs
PREX1 phosphatidylinositol-3,4,5-trisphosphate dependent Rac exchange factor 1
  • NRAGE signals death through JNK
  • Rho GTPase cycle
  • G alpha (12/13) signalling events
PREX2 phosphatidylinositol-3,4,5-trisphosphate dependent Rac exchange factor 2
  • Regulation of PTEN stability and activity

Page 5 out of 7 pages